Browse > Article
http://dx.doi.org/10.5012/bkcs.2009.30.2.435

Synthesis of (5R,8R)-2-(3,8-Dimethyl-2-oxo-1,2,4,5,6,7,8,8α-octahydroazulen-5-yl) Acrylic Acid (Rupestonic Acid) Amide Derivatives and in vitro Inhibitive Activities against Influenza A3,B and Herpes Simplex Type 1 and 2 Virus  

Yong, Jian-Ping (Xinjiang Technical Institute of Physics and Chemistry, The Key Laboratory of Plant Resources and Natural Products Chemistry, Chinese Academy of Science)
Lv, Qiao-Ying (Xinjiang Technical Institute of Physics and Chemistry, The Key Laboratory of Plant Resources and Natural Products Chemistry, Chinese Academy of Science)
Aisa, Haji Akber (Xinjiang Technical Institute of Physics and Chemistry, The Key Laboratory of Plant Resources and Natural Products Chemistry, Chinese Academy of Science)
Publication Information
Abstract
19 Aromatic ring and L-amino acid ester contained rupestonic acid amide derivatives 2a~2l, 3a~3g were synthesized and preliminarily evaluated in vitro against influenza virus $A_3$,B and herpes simplex virus type 1 (HSV-1), 2(HSV-2) by the national center for drug screening of China. The rusults showed that 2i possessed the highest inhibition against both influenza virus $A_3\;(TC_{50}\;=\;120.6\;{\mu}mol/L,\;IC_{50}=\;19.2\;{\mu}$mol/L, SI = 6.3) and B (T$C_{50}\;=\;120.6\;{\mu}mol/L,\;IC_{50}=\;29.9\;{\mu}$mol/L, SI = 4.0); 2g was more active against influenza $A_3$ virus at very low cytotoxicity ($TC_{50}\;>\;2092.1\;{\mu}mol/L,\;IC_{50}=\;143.7\;{\mu}mol/L,$ SI > 14.6) than the parent compound; Compounds 2b, 2c, 2f showed higher activities both against HSV-1 and HSV-2 than that of the parent compound, and 2f was the most potent inhibitor of HSV-1 ($TC_{50}\;=\;200.0\;{\mu}mol/L,\;IC_{50}\;=\;11.3\;{\mu}mol$/L, SI = 17.7 ) and HSV-2 ($TC_{50}\;=\;200.0\;{\mu}mol/L,\;IC_{50}\;=\;20.7\;{\mu}mol$/L , SI = 9.7).
Keywords
Synthesis; Rupestonic acid amide derivative; Anti-viral activities;
Citations & Related Records

Times Cited By Web Of Science : 1  (Related Records In Web of Science)
연도 인용수 순위
  • Reference
1 Wright, A. E.; Rueth, S. A.; Cross, S. S. J. Nat. Prod. 1991, 4, 1108.   DOI   ScienceOn
2 Liu, L. J.; Yong, J. P.; Wang, J. W. Chem. J. Chin. Universities 2006, 27, 1669.
3 Um, S. J.; Park, M. S.; Park, S. H.; Han, H. S.; Kwon, Y. J.;Sin, H. S. Bioorg. Med. Chem. 2003, 11, 5345.   DOI   ScienceOn
4 Byung, J. M.; Jong, W. C.; Oh, S. K. J. Korean Chem. Soc. 1991, 35, 78.   DOI   ScienceOn
5 Soon, U. K.; Nam, J. H. J. Korean Chem. Soc. 1987, 31, 475.
6 Smee, D. F.; Huffman, J. H.; Morrison, A. C.; Barnard, D. L.;Sidwell, R. W. Antimicrob. Agents Chemotherapy 2001, 45, 743.   DOI   ScienceOn
7 Reed, L. J.; Muench, H. Am. J. Hyg. 1938, 27, 493.   DOI   ScienceOn
8 Zhan, B. H.; Wang, Y. N.; Zhang, Y. Q. Chin. J. of Modern Med. 2005, 15, 1968.
9 Chen, X. Y.; Wang, S. H. Chin. Trad. & Herb. Drugs 1981, 12, 25.
10 Siirafil, E. B.; Askar, E. Y.; Ilhamjan, W. F. E. Chin. J. Biochem. & Mol. Biol. 2001, 17, 226.
11 Srapil, E. B.; Abdiryim, Y. S. F.; Gulnar, D. W. T. Chin. J. Integrated Trad. West. Med. 2002, 22, 126.
12 Srapil, E. B.; Gulnar, D. W. T.; Liu, F. Chin. J. Trad. Drugs 1996, 2, 35.
13 Aisa, H. A.; Yong, J. P.; Lv, Q. Y.; Wu, T. Acta Cryst. E 2008, 64, o479.   DOI
14 Sheu, J. H.; Hung, K. C.; Wang, G. H.; Duh, C. Y. J. Nat. Prod. 2000, 63, 1603.   DOI   ScienceOn